Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.11 is in line with its 5-year average of 2.27, around the middle of its 5-year range (0.89–4.00).
As of the fiscal period ended Tuesday, June 30, 2026. 3.77% above its 12-month average of 2.04.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.11.
QUICK RATIO (ACID-TEST)
2.11
QUICK RATIO (ACID-TEST) AVG TTM
2.04
QUICK RATIO (ACID-TEST) AVG 3Y
1.82
QUICK RATIO (ACID-TEST) AVG 5Y
2.27
QUICK RATIO (ACID-TEST) AVG 10Y
3.16
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.77%
CURRENT VS 3Y AVG
+16.43%
CURRENT VS 5Y AVG
-7.04%
CURRENT VS 10Y AVG
-33.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 622 covered companies
CURRENT VS SECTOR MEDIAN
-29.29%
vs the sector median at left
Seres Therapeutics, Inc.
Market Cap
$27.12M
Quick Ratio (Acid-Test)
2.11
TTM Avg
2.04
3Y Avg
1.82
5Y Avg
2.27
Market Cap
$27.82M
Quick Ratio (Acid-Test)
3.52
TTM Avg
5.18
3Y Avg
5.31
5Y Avg
5.55
Market Cap
$28.73M
Quick Ratio (Acid-Test)
5.12
TTM Avg
5.39
3Y Avg
5.72
5Y Avg
7.97
Market Cap
$29.52M
Quick Ratio (Acid-Test)
0.16
TTM Avg
1.60
3Y Avg
1.34
5Y Avg
1.09
Market Cap
$24.59M
Quick Ratio (Acid-Test)
5.69
TTM Avg
10.26
3Y Avg
14.54
5Y Avg
17.67
Market Cap
$24.47M
Quick Ratio (Acid-Test)
2.59
TTM Avg
2.35
3Y Avg
1.92
5Y Avg
2.36
Market Cap
$24.30M
Quick Ratio (Acid-Test)
0.07
TTM Avg
0.37
3Y Avg
0.39
5Y Avg
0.82
Market Cap
$30.51M
Quick Ratio (Acid-Test)
0.70
TTM Avg
2.07
3Y Avg
2.92
5Y Avg
4.15
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | $27.12M | 2.11 | 2.04 | 1.82 | 2.27 |
| InspireMD, Inc. (NSPR)vs › | $27.82M | 3.52 | 5.18 | 5.31 | 5.55 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.73M | 5.12 | 5.39 | 5.72 | 7.97 |
| GridAI Technologies Corp. (GRDX)vs › | $29.52M | 0.16 | 1.60 | 1.34 | 1.09 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.59M | 5.69 | 10.26 | 14.54 | 17.67 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.47M | 2.59 | 2.35 | 1.92 | 2.36 |
| CervoMed Inc. (CRVO)vs › | $29.81M | 8.57 | 7.97 | 5.03 | 6.79 |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.30M | 0.07 | 0.37 | 0.39 | 0.82 |
| BeyondSpring Inc. (BYSI)vs › | $30.51M | 0.70 | 2.07 | 2.92 | 4.15 |
| Context Therapeutics Inc. (CNTX)vs › | $30.63M | 5.81 | 22.07 | 14.94 | 12.78 |
Quick Ratio
2.11
Excludes inventory
Current Ratio
2.11
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.11 |
| 2026-03-31 | 1.65 |
| 2025-12-31 | 2.56 |
| 2025-09-30 | 2.30 |
| 2025-06-30 | 1.57 |
| 2025-03-31 | 2.11 |
| 2024-12-31 | 0.94 |
| 2024-09-30 | 1.12 |
| 2024-06-30 | 0.89 |
| 2024-03-31 | 1.25 |
| 2023-12-31 | 1.48 |
| 2023-09-30 | 2.47 |
| 2023-06-30 | 3.16 |
| 2023-03-31 | 1.82 |
| 2022-12-31 | 2.28 |
| 2022-09-30 | 3.03 |
| 2022-06-30 | 2.35 |
| 2022-03-31 | 3.20 |
| 2021-12-31 | 3.69 |
| 2021-09-30 | 3.79 |
| 2021-06-30 | 4.00 |
| 2021-03-31 | 5.26 |
| 2020-12-31 | 5.79 |
| 2020-09-30 | 6.73 |
| 2020-06-30 | 1.64 |
| 2020-03-31 | 1.83 |
| 2019-12-31 | 2.18 |
| 2019-09-30 | 2.12 |
| 2019-06-30 | 2.53 |
| 2019-03-31 | 1.63 |
| 2018-12-31 | 2.20 |
| 2018-09-30 | 2.04 |
| 2018-06-30 | 2.76 |
| 2018-03-31 | 3.60 |
| 2017-12-31 | 4.90 |
| 2017-09-30 | 6.53 |
| 2017-06-30 | 6.86 |
| 2017-03-31 | 7.06 |
| 2016-12-31 | 6.51 |
| 2016-09-30 | 6.54 |
| 2016-06-30 | 7.94 |
| 2016-03-31 | 12.36 |
| 2015-12-31 | 19.01 |
| 2015-09-30 | 45.89 |
| 2015-06-30 | 16.68 |
| 2015-03-31 | 30.59 |
| 2014-12-31 | 22.39 |
| 2014-09-30 | 2.67 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 1.61 |
